What can CGM actually tell you about your health right now?
For people with diabetes, CGM is a proven tool for personalized management. The largest and highest-quality study among these—a randomized controlled trial of 156 adults with type 1 diabetes—found that using an intermittently scanned CGM with optional alarms lowered HbA1c by 0.5 percentage points more than standard fingerstick testing over 24 weeks, and added 130 more minutes per day in the target glucose range of 70–180 mg/dL [3]. Another study in type 2 diabetes and prediabetes showed that combining CGM with personalized digital health coaching for 8 weeks reduced HbA1c from 7.39% to 6.82% in those with the highest glucose variability [2]. These are real, clinically meaningful improvements.
For people without diabetes, CGM can still provide useful personalized feedback, but the benefits are less dramatic. In a real-world analysis of over 1,300 people without diabetes using a CGM-integrated app, those who logged meals more frequently spent more time in a healthy glucose range (70–140 mg/dL) and had lower maximum glucose values than those who logged less [1]. The same study showed that people with higher BMIs had higher average glucose and less time in range, suggesting CGM can help individuals see how their weight and eating habits affect their glucose—even if they don't have a diagnosis [1].
What are the limitations—can you really trust the numbers?
CGM is accurate enough for day-to-day decisions, but it's not perfect. In a large accuracy study of the Dexcom G7 sensor in adults with diabetes, the mean absolute relative difference (MARD)—a measure of how far off the sensor reading is from a lab reference—was 8.2% for arm placement, meaning the average error is small [5]. However, a separate study that had people with type 2 diabetes wear two different CGM sensors simultaneously found that the two sensors could differ by an average of 13 mg/dL in mean glucose, and by 8 percentage points in time in range [7]. That means your personalized recommendation might change depending on which sensor you use.
Another limitation: people often stop using CGM after the initial period. In a large analysis of over 7,600 users of a CGM-integrated app, only 30% completed two or more sensor wear periods (28+ days), and food logging dropped sharply once the sensor was removed [4]. This suggests that sustained engagement—not just the technology—is a major barrier to getting long-term personalized recommendations. The same study found that people with higher baseline glucose wore the sensor longer but logged food less, hinting that passive monitoring and active behavior tracking may require different motivational strategies [4].
Who gets the most out of CGM-based recommendations?
The evidence clearly shows that people with diabetes or prediabetes benefit most. In the randomized trial for type 1 diabetes, the CGM group saw a 0.5% HbA1c drop and 130 more minutes in range [3]. In type 2 diabetes and prediabetes, those with the highest glucose variability (the most ups and downs) had the biggest improvements—a 0.57% HbA1c reduction—after 8 weeks of CGM plus coaching [2]. Even in rare metabolic conditions like glycogen storage disorders, CGM helped clinicians make personalized dietary adjustments that reduced hypoglycemia duration in all 10 patients who received follow-up monitoring [9].
For people without diabetes, the benefits are more modest and less certain. One study of a worksite health screening that included blinded CGM found that people with prediabetes had higher average glucose and less time in range than a normative sample, suggesting CGM can identify at-risk individuals who might benefit from lifestyle changes [6]. But a scoping review of 45 studies on CGM-based personalized nutrition in type 2 diabetes concluded that while the approach shows promise, the evidence is methodologically inconsistent, with few studies measuring behavioral or long-term outcomes [8]. So if you're healthy and just curious, CGM can give you interesting data, but the personalized recommendations you get may not be backed by strong evidence yet.
About These Sources
This answer is built on 9 peer-reviewed studies — published from 2020 to 2026, 5 from 2024 or later, 3 in Q1 journals, collectively cited 301 times — selected as the most relevant from 12 studies that passed quality screening, drawn from 79 papers retrieved from a database of over 500 million.
Sources used in this answer
984-P: Exploring the Impact of Dexcom CGM and Levels Metabolic Health App’s Meal Logging Feature on Glycemic Outcomes and Behaviors across BMI Categories in a Real-World Cohort without Diabetes
In a real-world study of 1,304 people without diabetes using Dexcom CGM and a meal-logging app, those with above-median meal logging spent more time in glucose target ranges and had lower maximum glucose, while higher BMI was linked to higher average glucose and less time in range [1].
Impact of real-time continuous glucose monitoring and personalized digital health coaching on glycemic control and lifestyle in patients with type 2 diabetes and prediabetes.
In a prospective cohort study of 110 people with type 2 diabetes or prediabetes, 8 weeks of CGM plus personalized digital health coaching reduced HbA1c from 7.39% to 6.82% in the highest glucose variability group, with improved physical activity and dietary habits [2].
Intermittently Scanned Continuous Glucose Monitoring for Type 1 Diabetes
In a randomized controlled trial of 156 adults with type 1 diabetes and high HbA1c, intermittently scanned CGM with optional alarms lowered HbA1c by 0.5 percentage points more than fingerstick testing and added 130 more minutes per day in target glucose range over 24 weeks [3].
Continuous Glucose Monitoring for Personalized Nutrition in Real-World Vively App Users: Retrospective Observational Study
In a retrospective study of 7,647 users of a CGM-integrated app, only 30% completed two or more sensor wear periods (28+ days), and food logging dropped sharply after sensor removal, with higher baseline glucose linked to longer CGM wear but fewer food logs [4].
Accuracy and Safety of Dexcom G7 Continuous Glucose Monitoring in Adults with Diabetes
In a multicenter study of 316 adults with diabetes, the Dexcom G7 CGM had a mean absolute relative difference (MARD) of 8.2% for arm placement and 9.1% for abdomen, with no serious adverse events [5].
82-LB: Including Continuous Glucose Monitoring (CGM) to Provide Personalized Glycemic Profiles as Part of a Pilot Worksite Health Screening
In a pilot worksite health screening of 207 employees (85% with CGM data for ≥4 days), blinded CGM identified 7 previously undiagnosed type 2 diabetes and 24 prediabetes cases, and those with prediabetes had higher mean glucose and lower time in range than a normative sample [9].
Within-Person and Between-Sensor Variability in Continuous Glucose Monitoring Metrics.
In a secondary analysis of 172 adults with type 2 diabetes not on insulin, two different CGM sensors worn simultaneously had a correlation of r=0.86 for mean glucose but differed by an average of 13 mg/dL, and within-person variability over 3 months was substantial (CVw ~14–20% for key metrics) [10].
Continuous Glucose Monitoring and Personalized Nutrition in Type 2 Diabetes - A Scoping Review.
A scoping review of 45 studies on CGM-based personalized nutrition in type 2 diabetes found that interventions included CGM-guided nutrition, AI-enabled prediction, and telehealth coaching, but outcomes were mostly limited to HbA1c and time in range, with few behavioral or long-term measures [11].
Personalized management of hepatic glycogen storage disorders: The role of continuous glucose monitoring.
In a pre-post study of 20 children with hepatic glycogen storage disorders, CGM-guided dietary adjustments reduced hypoglycemia duration in all 10 patients who received follow-up monitoring, with improvements in growth and metabolic parameters [12].